AVIR
Atea Pharmaceuticals, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report1 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
+0.20%
vs ±11.0% implied · ×0.02
shaded = implied · ▲▼ = realized
No thesis.
Fund move
Fund move
Atea Pharmaceuticals, Inc.
4.11
−0.20 · −4.64%
post 4.11 0.00%
Linked news
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | FMRFMR | $55.8M | 20.20% | +0.45% | |
| 2 | BlackRockBlackRockindex-like | $40.5M | 14.67% | +3.37% | |
| 3 | BML Capital ManagementBML | $32.3M | 11.70% | −1.51% | |
| 4 | Tang Capital ManagementTang | $22.4M | 8.10% | 0.00% | |
| 5 | Vanguard Capital ManagementVanguardindex-like | $13.8M | 4.99% | −8.66% | |
| 6 | Bain Capital Life Sciences InvestorsBain Capital Life Sciences Investors | $9.7M | 3.49% | −12.07% | |
| 7 | Acadian Asset ManagementAcadian | $9.5M | 3.42% | +28.58% | |
| 8 | Geode Capital ManagementGeodeindex-like | $9.1M | 3.30% | +12.06% | |
| 9 | State StreetState Streetindex-like | $7.7M | 2.78% | −2.49% | |
| 10 | Two Sigma InvestmentsTwo Sigma | $7.0M | 2.53% | −19.18% | |
| 11 | Dimensional Fund AdvisorsDimensional | $6.0M | 2.19% | +3.51% | |
| 12 | Renaissance TechnologiesRenaissance Technologies | $5.3M | 1.90% | −3.02% | |
| 13 | Rosalind AdvisorsRosalind | $5.0M | 1.80% | −8.64% | |
| 14 | JPMorgan ChaseJPMorgan Chase | $4.4M | 1.58% | new | |
| 15 | Northern TrustNorthern Trustindex-like | $3.5M | 1.27% | +29.10% | |
| 16 | Morgan StanleyMorgan Stanley | $3.3M | 1.21% | −1.57% | |
| 17 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $2.9M | 1.06% | +13.02% | |
| 18 | Charles Schwab Investment ManagementCharles Schwabindex-like | $2.8M | 1.03% | +2.33% | |
| 19 | Goldman Sachs GroupGoldman Sachs | $2.5M | 0.89% | −9.79% | |
| 20 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $2.2M | 0.79% | new | |
| 21 | CM ManagementCM Management | $1.7M | 0.60% | 0.00% | |
| 22 | BarclaysBarclays | $1.6M | 0.59% | +116.63% | |
| 23 | D. E. ShawD. E. Shaw | $1.6M | 0.58% | −9.00% | |
| 24 | Banque Pictet & CIEBanque Pictet & CIE | $1.6M | 0.58% | 0.00% | |
| 25 | Millennium ManagementMillennium | $1.4M | 0.51% | −12.95% |
123 managers report $276.4M of Atea Pharmaceuticals on form 13F for the quarter ended Jun 30 '26. 13 of them hold 80% of it; FMR is largest at 20.20%.
Expected move
No implied move.
No implied move.
No implied move.